Unknown

Dataset Information

0

A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule.


ABSTRACT: A number of autoimmune diseases are associated with the genotypes of human leukocyte antigen class II (HLA), some of which present peptides derived from self-proteins, resulting in clonal expansion of self-reactive T cells. Therefore, selective inhibition of self-peptide loading onto such disease-associated HLA could ameliorate the diseases. To effectively identify such compounds, in this study, we established, for the first time, a cell- and 96-well microplate-based high-throughput screening system for inhibitors of antigen presentation. A panel of DRB1 genes plus DRA*01:01 gene were expressed in HEK293T cells and in 3T3 cells, and their binding with biotinylated known self-antigen peptides was measured by flow cytometry. HLA-DR1 (DRB1*01:01) and DR15 (DRB1*15:01) showed a high affinity with myelin basic protein peptide (MBP83-98). Therefore, in 96-well plate wells, MBP83-99 was allowed to bind to DR1 or DR15 on 3T3 cells in competition with a test compound, and the HLA-bound peptide was detected by streptavidin-conjugated ?-galactosidase, thereby identifying inhibitor compounds for rheumatoid arthritis or multiple sclerosis. Our assay system has a potential for broad applications, including designing peptide vaccines.

SUBMITTER: Watanabe N 

PROVIDER: S-EPMC5533769 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule.

Watanabe Nobuo N   Suzuki Yusuke Y   Yonezu Takahisa T   Nakagawa Yuki Y   Shiina Takashi T   Hirayama Noriaki N   Inokuchi Sadaki S   Inoue Shigeaki S  

Scientific reports 20170728 1


A number of autoimmune diseases are associated with the genotypes of human leukocyte antigen class II (HLA), some of which present peptides derived from self-proteins, resulting in clonal expansion of self-reactive T cells. Therefore, selective inhibition of self-peptide loading onto such disease-associated HLA could ameliorate the diseases. To effectively identify such compounds, in this study, we established, for the first time, a cell- and 96-well microplate-based high-throughput screening sy  ...[more]

Similar Datasets

| S-EPMC7075463 | biostudies-literature
| S-EPMC34432 | biostudies-literature
| S-EPMC5025652 | biostudies-literature
| S-EPMC3891844 | biostudies-literature
| S-EPMC6856845 | biostudies-literature
| S-EPMC3288754 | biostudies-literature
| S-EPMC8108382 | biostudies-literature
| S-EPMC2213310 | biostudies-literature
| S-EPMC8270262 | biostudies-literature
| S-EPMC4817760 | biostudies-literature